Updated guidance on AstraZeneca vaccine sparks further confusion

Canada’s vaccine advisory committee changed its guidance on the AstraZeneca-Oxford COVID-19 vaccine, recommending it be given to those over the age of 65. But it has sparked more confusion by saying if given the choice, Pfizer-BioNTech's and Moderna's were still preferable for seniors.